Abstract Submission Guidelines

Electronic Submission: All abstracts for the 2026 Annual Meeting must be submitted electronically at https://asv2026.abstractcentral.com/ for processing, evaluation and inclusion in the ASV 2026 Scientific Program & Abstracts. Complete instructions for electronic submission protocols are provided on the abstract submission website.

Deadline: Deadline for receipt of electronic abstracts is Monday, February 2, 2026 at 11:59 pm Eastern Time.

Presentation format options: Abstract submitters can apply to give an oral talk, flash talk with poster, or a poster.

  • Oral talks are 12-minute presentations, with 3 minutes for questions and answers.
  • Flash talks with posters use a short “elevator pitch” format to advertise a poster and draw the audience to a subsequent poster session for further discussion. Flash talks will be 3 minutes with a maximum of 2 slides, and no time for questions.
  • Posters will be presented in a standard scientific poster session format.

Additional information, details, and tips for each presentation format is provided on ASV’s website here.

*IMPORTANT NOTES*

Abstract Authorship: The first author listed in the list of authors on the abstract must be the person who will actually present the talk or poster. You will also list the email address of this first author (first = presenting author) on the submission form and they will receive all email notifications regarding the date, session and time of presentation. During abstract submission, you will also be asked to identify the Principal Investigator (PI) for this research, e.g., the lab head or project leader.

Withdrawal: Because withdrawal of an abstract greatly disrupts the continuity of the program, do not request a workshop (oral) presentation unless you are certain that you or a co-author will attend ASV and be able to present your research at the meeting.

Abstract acceptance and presentation format assignment: Acceptance of abstracts submissions for presentation at the ASV Annual Meeting is based on the scientific quality of the submitted abstract. Please see below for guidance on ASV abstract content. Every attempt will be made to honor your presentation preference. However, because of the large number of abstracts, not all oral and flash talk presentation format requests can be accommodated.
If an emergency arises and you must withdraw your abstract (and no co-author is able to make the presentation in your place), you must immediately notify the ASV Office via email at [email protected] or by telephone at 734-764-9686.

Instructions

Word Count: Maximum number of words for the abstract text: 300.

Abstract Title: The title should be concise and informative. Avoid superfluous words such as "preliminary studies on" etc.

Abstract Content: The abstract should educate the reader by clearly stating the originality of the work and its specific conclusions. A good scientific abstract should convey 1) the context and goal of your research, 2) the approach or method(s), 3) the key results, and 4) why this is impactful. It is NOT appropriate to state: "The results will be discussed.” All abstracts will be reviewed by the Program Committee but will not be edited. Carefully proofread your abstract for errors. Further examples and guidance on how to prepare a scientific conference abstract can be found here or here. 

Tables and Figures: These items are permitted in the abstract.

Topics & Themes: During abstract submission, you will be asked to select 2 topics that best reflect your presentation – one based on Virus Type, and one based on Research Areas. These topic choices will be used to help place abstracts in related sessions. There will be a checkbox where you can indicate which of these topics you would prefer your abstract to be grouped with, if possible.

Virus Type

Adeno-, Papilloma-, & Polyomaviruses
Arenaviruses
Arthropod-borne viruses (Arboviruses)
Bacteriophages & Archaeal viruses
Bornaviruses
Bunyaviruses
Calici- & Astroviruses
Coronaviruses & Arteriviruses
Filoviruses
Flaviviruses
Giant viruses, Fungal viruses, & Algal viruses
Hepatitis Viruses
Herpesviruses
Invertebrate Viruses
Orthomyxoviruses
Paramyxoviruses & Pneumoviruses
Parvo- & Circoviruses
Picornaviruses
Plant Viruses
Poxviruses
Reoviruses & Birnaviruses
Retroviruses
Rhabdoviruses
Rotaviruses
Togaviruses

Virus Research Area

Adaptive Immunity
Antiviral Therapies
Careers Workshop Only
Chromatin Biology
Chronic, Latent & Persistent Infections
Computational Virology and Modeling
Cytokines, Chemokines, & their Receptors
Emerging Viruses
Epidemiology & Public Health
Evolution, Ecology, & Reservoirs
Innate Immune Effector Functions
Innate Immune Sensing
Non-coding RNAs
Novel Methodology & Technology
Pathogenesis
Physiological Barriers to Infection
Polymicrobial or Multi-virus Interactions
Receptors, Attachment & Entry
Replication & Gene Expression
Reverse Transcription & Integration
RNA Biology
Signal Transduction
Single Cell Virology
Structural Virology
Systems Biology & Metabolism
Trafficking, Assembly, Egress, & Transmission
Tumor virology, Transformation & Oncogenesis
Vaccines
Veterinary Virology
Viral Interference with Host Defense
Virology Education
Virus Discovery
Virus-triggered Cell Death Pathways
Virus Vector, Virus-based Gene Therapy